Journal article 735 views 174 downloads
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
Stephen C. Bain,
Ofri Mosenzon,
Rosario Arechavaleta,
Pawel Bogdański,
Abdurrahman Comlekci,
Agostino Consoli,
Chaicharn Deerochanawong,
Kathleen Dungan,
Maria C. Faingold,
Michael E. Farkouh,
Denise R. Franco,
Jeppe Gram,
Cristian Guja,
Pankaj Joshi,
Rachid Malek,
Juan F. Merino-Torres,
Michael A. Nauck,
Sue D. Pedersen,
Wayne H. -H. Sheu,
Robert J. Silver,
Cees J. Tack,
Nikhil Tandon,
Ole K. Jeppesen,
Mette Strange,
Mette Thomsen,
Mansoor Husain,
Steve Bain 
Diabetes, Obesity and Metabolism
Swansea University Author:
Steve Bain
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC-ND).
Download (856.24KB)
DOI (Published version): 10.1111/dom.13553
Abstract
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| ISSN: | 14628902 |
| Published: |
2018
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa44806 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|